Evidence map›Paper›PMID 42172654›Full record

ArticleInteractive journal of medical research2026

Innovation Deimplementation in Emergency Departments During the COVID-19 Pandemic: Qualitative Study of Clinicians' Decision-Making.

Shreya Huilgol, Nabeel Qureshi, Carl Berdahl, Catherine Cohen, Peter Mendel, Shira Fischer

Abstract read
In one paragraph

Article in Interactive journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shreya HuilgolDepartment of Health Policy and Management, University of California, Los Angeles, 650 Charles E Young Dr S, Los Angeles, CA, 90095, United States, 1 (310) 825-6381.ORCID http://orcid.org/0000-0003-2596-0289
Nabeel QureshiRAND, Santa Monica, CA, United States.ORCID http://orcid.org/0000-0001-7782-8023
Carl BerdahlRAND, Santa Monica, CA, United States.ORCID http://orcid.org/0000-0002-4374-3280
Catherine CohenRAND, Santa Monica, CA, United States.ORCID http://orcid.org/0000-0001-7100-1535
Peter MendelRAND, Santa Monica, CA, United States.ORCID http://orcid.org/0000-0002-2816-9559
Shira FischerRAND, Boston, MA, United States.ORCID http://orcid.org/0000-0002-1124-4962

Funding

Dissemination and Implementation of COVID-19 Care Innovations in ED SettingsR01AI169293 · NIAID · RAND CORPORATION · PI FISCHER, SHIRA HANNAH, MENDEL, PETER JAMES · 2022 to 2025
$3.2M
NIAID NIH HHS R01 AI169293
6 · The paper itself

Abstract

Background: During a public health emergency, emergency department (ED) clinicians can improve care delivery if they identify and adopt innovations that are safe and effective. However, little is known about the factors that impact ED clinicians' decision-making around using or discontinuing innovations when evidence-based information is limited. Objective: The goal of this study was to understand the processes and factors that led ED clinicians to discontinue (deimplement) the use of COVID-19 care innovations. Methods: This is a qualitative study using semistructured focus groups with ED clinicians from 8 hospitals across the United States. Hospitals were purposively sampled and recruited to capture a diversity of perspectives based on location, facility type (academic or community hospital), rurality (urban or rural), and safety-net status. In this study, 17 physicians, 7 advanced practice providers, 18 nurses, and 7 respiratory therapists participated. We utilized both inductive and deductive techniques to perform content and thematic analysis of transcripts. Results: Clinicians shared that their own experiences (eg, direct observation of patient outcomes), contextual factors, and emerging research evidence contributed heavily to decisions about deimplementing innovations during the COVID-19 pandemic. Processes related to discontinuing innovations depended on leadership guidance and collaboration among colleagues. However, in some cases, there were no official processes to discontinue innovations, and innovations were passively deimplemented. Conclusions: Decision-making regarding the discontinuation of innovation in ED settings during the COVID-19 pandemic differed from routine conditions due to the lack of information and the rapid evolution of evidence within a short period of time. The level of evidence required to implement and deimplement innovations was significantly lower. Our findings indicate that factors influencing deimplementation during a public health emergency were highly localized and were treated similarly to pilot tests of new innovations. Future work is necessary to develop mechanisms for implementing promising innovations during evolving public health emergencies and monitoring their effectiveness and safety after implementation, enabling evidence-based decisions about whether to continue implementation or proceed with deimplementation.

Indexed as

COVID-19 pandemicdecision-makingdeimplementationemergency departmentinnovation

Identifiers

PMID42172654
PMCPMC13197154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.